DNA damage-induced PARP1 activation confers cardiomyocyte dysfunction through NAD+ depletion in experimental atrial fibrillation
Deli Zhang, Xu Hu, Jin Li et al. · Nature Communications · 2019
Full textCC BY
10 papers · Closest matches first
Deli Zhang, Xu Hu, Jin Li et al. · Nature Communications · 2019
Full textCC BY
Paul E. Sax, Juliana L. Meyers, Michael Mugavero et al. · PLoS ONE · 2012
Full textCC BY
Min Huang, Shaoli Cai, Jingqian Su · International Journal of Molecular Sciences · 2019 · Review
Full textCC BY
J Gomez · BMC Oral Health · 2015 · Review
Full textCC BY
Paul Lesueur, François Chevalier, Jean-Baptiste Austry et al. · Oncotarget · 2017 · Review
Full textCC BY
Raquel Dias, Ali Torkamani · Genome Medicine · 2019 · Review
Full textCC BY
Richard Hayes, Helen Ayles, Nulda Beyers et al. · Trials · 2014 · Randomised trial
Full textCC BY
Kiran Jobanputra, Lucy Anne Parker, Charles Azih et al. · PLOS ONE · 2015
Full textCC BY
Nguyen T. T. Thuong, Dorothee Heemskerk, Trinh T. B. Tram et al. · The Journal of Infectious Diseases · 2017 · Randomised trial
Full textCC BY
Stephen D. Lawn, Sophie V. Brooks, Katharina Kranzer et al. · PLoS Medicine · 2011
Full textCC BY
A status comes from the publisher’s own notices and from Retraction Watch. “Not checked” means nobody has checked this paper yet. It is not the same as “No notice”.